The National Comprehensive Cancer Network (NCCN)

company

About

National Comprehensive Cancer Network is a not-for-profit alliance of 26 of the world's leading cancer centers.

  • 51 - 100

Details

Last Funding Type
Grant
Industries
Health Care,Hospital,Non Profit
Founded date
Jan 1, 1995
Number Of Employee
51 - 100
Operating Status
Active

The National Comprehensive Cancer Network® (NCCN®), a not-for-profit alliance of 26 of the world's leading cancer centers devoted to patient care, research, and education, is dedicated to improving the quality, effectiveness, and efficiency of cancer care so that patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system. As the arbiter of high-quality cancer care, NCCN promotes the importance of continuous quality improvement and recognizes the significance of creating clinical practice guidelines appropriate for use by patients, clinicians, and other health care decision-makers.

World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers. NCCN Member Institutions pioneered the concept of the multidisciplinary team approach to patient care and conduct innovative research that contributes significantly to understanding, diagnosing, and treating cancer. NCCN programs offer access to expert physicians, superior treatment, and quality and safety initiatives that continuously improve the effectiveness and efficiency of cancer care.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
The National Comprehensive Cancer Network (NCCN) has raised a total of — in funding over 2 rounds. Their latest funding was raised on Nov 4, 2021 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 4, 2021 Grant 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
The National Comprehensive Cancer Network (NCCN) is funded by 1 investors. Pfizer are the most recent investors.
Investor Name Lead Investor Funding Round
Pfizer Grant